Actively Recruiting
Exploratory Analysis of Enhanced Liver Function (ELF) Test to Detect Early Fatty Liver in High Risk Population
Led by Methodist Health System · Updated on 2026-05-13
300
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are investigating the use of the Enhanced Liver Fibrosis (ELF) test to detect early signs of fatty liver disease in people at high risk for nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). This study focuses on patients with metabolic syndrome or related conditions such as high cholesterol, coronary artery disease, heart failure, hypertension, and type 2 diabetes. The goal is to better understand how ELF scores relate to liver fibrosis and liver-related health events in this population, filling gaps in current knowledge.
CONDITIONS
Brief Title
Exploratory Analysis of Enhanced Liver Function (ELF) Test to Detect Early Fatty Liver in High Risk Population
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Patients with or without NAFLD/NASH who have had an ELF score assessment at Methodist Dallas Medical Center from November 2021 to December 2023
You will not qualify if you...
- Patients with incomplete data
- Patients lost to follow up
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 2 years
Participants undergo ELF serum tests and other assessments to evaluate liver fibrosis and related conditions.
Assessments occur at the time of routine clinical care between November 2021 and December 2023
Duration - Up to 6 months following initial assessments
Participants are observed to track liver-related outcomes, hospital admissions, and comorbidities over time.
Follow-up data collected during routine clinical visits
Trial Site Locations
Total: 1 location
1
Methodist Dallas Medical Center
Dallas, Texas, United States, 75203
Actively Recruiting
Research Team
C
Crystee Cooper
J
Jennifer Kirchner
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here